Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reduction of amyloid beta peptide production via modification of the APP gene using the CRISPR/Cas system

Reduction of amyloid beta peptide production via modification of the APP gene using the CRISPR/Cas system

US Patent 10280419 · Granted May 7, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CRISPR-based methods and products for increasing frataxin levels and uses thereo2019
CRISPR-based methods and products for increasing frataxin levels and uses thereo2019
CRISPR-based methods and products for increasing frataxin levels and uses thereo2019
Methods and products for increasing frataxin levels and uses thereof2017
Methods and products for increasing frataxin levels and uses thereof2017
Methods and products for increasing frataxin levels and uses thereof2017
Culture medium for myoblasts, precursors thereof and derivatives thereof2015
Myogenic differentiation of stem cells and uses thereof2014
Meganuclease reagents of uses thereof for treating genetic diseases caused by fr2014
Prostaglandin E2 modulation and uses thereof2013
Treatment of Duchenne muscular dystrophy with myoblasts expressing dystrophin an2011
Method of in vitro preconditioning healthy donor's myoblasts before transplantat2007